Harvey Norman Holdings Limited
HNORY · OTC
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Market Cap | $5 | $6 | $4 | $6 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $2 | $2 | $2 | $2 |
| Enterprise Value | $7 | $8 | $6 | $7 |
| Revenue | $4 | $4 | $4 | $4 |
| % Growth | 5.1% | -1.6% | -3.9% | – |
| Gross Profit | $2 | $2 | $2 | $2 |
| % Margin | 51% | 50.8% | 48.7% | 51.1% |
| EBITDA | $1 | $1 | $1 | $1 |
| % Margin | 25.8% | 21.3% | 27.1% | 33.7% |
| Net Income | $1 | $0 | $1 | $1 |
| % Margin | 12.6% | 9% | 13.5% | 19.6% |
| EPS Diluted | 2.1 | 1.4 | 2.15 | 3.25 |
| % Growth | 50% | -34.9% | -33.8% | – |
| Operating Cash Flow | $1 | $1 | $1 | $1 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $1 | $0 | $0 | $1 |